Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
NKA-M52H5 | Mouse | Mouse NKG2A / CD159a Protein, His Tag | ![]() |
![]() ![]() |
|
NKA-C5245 | Cynomolgus | Cynomolgus NKG2A / CD159a Protein, His Tag | ![]() |
![]() ![]() |
|
NKA-H526c | Human | Human NKG2A / CD159a Protein, Fc Tag | ![]() |
![]() ![]() |
|
NKA-H5244 | Human | Human NKG2A / CD159a Protein, His Tag | ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
S-095029 | S-095029 | Institut De Recherches Internationales Servier | Details | ||
Monalizumab | NN-8765; IPH-2201; NNC-0141-0000-0100 | Phase 3 Clinical | Novo Nordisk A/S, Innate | Ovarian Neoplasms; Solid tumours; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Arthritis, Rheumatoid; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Squamous Cell; Mouth Neoplasms; Inflammation; Carcinoma, Non-Small-Cell Lung; Leukemia, Lymphocytic, Chronic, B-Cell; Uterine Cervical Neoplasms | Details |
This web search service is supported by Google Inc.